G. HATEMİ Et Al. , "IMPROVEMENTS AND CORRELATIONS IN ORAL ULCERS, DISEASE ACTIVITY, AND QOL IN BEHCET'S SYNDROME PATIENTS TREATED WITH APREMILAST: A PHASE 3 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY," 19th International Vasculitis and ANCA Workshop , vol.58, Pennsylvania, United States Of America, pp.111, 2019
HATEMİ, G. Et Al. 2019. IMPROVEMENTS AND CORRELATIONS IN ORAL ULCERS, DISEASE ACTIVITY, AND QOL IN BEHCET'S SYNDROME PATIENTS TREATED WITH APREMILAST: A PHASE 3 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY. 19th International Vasculitis and ANCA Workshop , (Pennsylvania, United States Of America), 111.
HATEMİ, G., Mahr, A., Takeno, M., Kim, D., Melikoglu, M., Cheng, S., ... Mccue, S.(2019). IMPROVEMENTS AND CORRELATIONS IN ORAL ULCERS, DISEASE ACTIVITY, AND QOL IN BEHCET'S SYNDROME PATIENTS TREATED WITH APREMILAST: A PHASE 3 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY . 19th International Vasculitis and ANCA Workshop (pp.111). Pennsylvania, United States Of America
HATEMİ, Gülen Et Al. "IMPROVEMENTS AND CORRELATIONS IN ORAL ULCERS, DISEASE ACTIVITY, AND QOL IN BEHCET'S SYNDROME PATIENTS TREATED WITH APREMILAST: A PHASE 3 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY," 19th International Vasculitis and ANCA Workshop, Pennsylvania, United States Of America, 2019
HATEMİ, Gülen Et Al. "IMPROVEMENTS AND CORRELATIONS IN ORAL ULCERS, DISEASE ACTIVITY, AND QOL IN BEHCET'S SYNDROME PATIENTS TREATED WITH APREMILAST: A PHASE 3 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY." 19th International Vasculitis and ANCA Workshop , Pennsylvania, United States Of America, pp.111, 2019
HATEMİ, G. Et Al. (2019) . "IMPROVEMENTS AND CORRELATIONS IN ORAL ULCERS, DISEASE ACTIVITY, AND QOL IN BEHCET'S SYNDROME PATIENTS TREATED WITH APREMILAST: A PHASE 3 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY." 19th International Vasculitis and ANCA Workshop , Pennsylvania, United States Of America, p.111.
@conferencepaper{conferencepaper, author={Gülen HATEMİ Et Al. }, title={IMPROVEMENTS AND CORRELATIONS IN ORAL ULCERS, DISEASE ACTIVITY, AND QOL IN BEHCET'S SYNDROME PATIENTS TREATED WITH APREMILAST: A PHASE 3 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY}, congress name={19th International Vasculitis and ANCA Workshop}, city={Pennsylvania}, country={United States Of America}, year={2019}, pages={111} }